Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 2, 1996, Pages 572-575

  Sestini, Piersante ^a   Armetti, Laura ^b   Gambaro, Cabriella ^b   Pieroni, Maria G ^b   Refini, Rosa M ^b   Sala, Angelo ^b   Vaghi, Adriano ^b   Folco, Gian C ^b   Bianco, Sebastiano ^b   Robuschi, Maria ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE E4; LYSINE ACETYLSALICYLATE; PROSTAGLANDIN E2; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID LYSINATE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; LYSINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INHALATIONAL DRUG ADMINISTRATION; MALE; OBSTRUCTIVE AIRWAY DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BRONCHOSPASM; CHEMICALLY INDUCED DISORDER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALATION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; URINE;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ASPIRIN; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE E4; LYSINE; MALE; MIDDLE AGED;

EID: 0029664976     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.2.8564100     Document Type: Article

References (34)

1. Szczeklik, A., R. J. Gryglewski, and G. Czerniawska-Mysik. 1975. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. B.M.J. 1:67-69.
2. Samter, M., and R. Beers. 1968. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68:975-983.
3. Stevenson, D. D., and R. A. Simon. 1988. Aspirin sensitivity: respiratory and cutaneous manifestations. In E. Middleton, C. Reed, E. E. Ellis, N. F. Adkinson, and I. V. Jungiger, editors. Allergy, Principle and Practice, 3rd ed. Mosby, St. Louis. 1537-1554.
4. Szczeklik, A. 1990. The cyclooxygenase theory of aspirin-induced asthma. Eur. Respir. J. 3:588-593.
5. Lee, T. H. 1993. Mechanism of bronchospasm in aspirin-sensitive asthma. Am. Rev. Respir. Dis. 148:1442-1443.
6. Pasargiklian, M., S. Bianco, L. Allegra, N. E. Moavero, G. Petrigni, M. Robuschi, and A. A. Grugni. 1977. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 34:79-91.
7. Kumlin, M., B. Dahlén, T. Björk, O. Zetterström, E. Granström, and S. E. Dahlén. 1992. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4 and histamine in asthmatics. Am. Rev. Respir. Dis. 146:96-103.
8. 4 after lysine-aspirin by inhalation in asthmatic subjects. Am. Rev. Respir. Dis. 146:1531-1534.
9. Dahlén, B., M. Kumlin, D. J. Margolskee, C. Larsson, H. Blomqvist, V. C. Williams, O. Zettelström, and S. Dahlén. 1993. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur. Respir. J. 6:1018-1026.
10. Chai, H., R. S. Farr, L. A. Froelich, D. A. Mathison, J. A. McLean, R. R. Rosenthal, A. L. Sheffer, S. L. Spector, and R. G. Townley. 1975. Standardization of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 56:323-327.
11. Sestini, P., M. G. Pieroni, R. M. Refini, M. Robuschi, G. Gambaro, S. Spagnotto, A. Vaghi, and S. Bianco. 1994. Time-limited protective effect of inhaled furosemide against aspirin-induced bronchoconstriction in aspirin sensitive asthmatics. Eur. Respir. J. 7:1825-1829.
12. Bianco, S., M. Robuschi, and G. Petrigni. 1977. Aspirin induced tolerance in aspirin asthma detected by a new challenge test. IRCS J. Med. Sci. 5:129.
13. Bianco, S., M. Robuschi, and G. Petrigni. 1981. Aspirin sensitivity in asthmatics (letter). B.M.J. 282:116.
14. 2 on allergen-induced asthma. Am. Rev. Respir. Dis. 148:87-90.
15. 4. Prostaglandins 47:281-292.
16. Dunnett, C. W. 1964. New tables for multiple comparison with a control. Biometrics 20:482-491.
17. Snedecor, G. W., and W. G. Cochran. 1980. Statistical Methods, 7th ed. Iowa State University Press, Ames, IA.
18. 2) on airway obstruction induced by aspirin (ASA) in aspirin intolerant asthmatics (AIA). Eur. Respir. J. 7:434S.
19. Haye-Legrand, I., J. Cerrina, B. Raffestin, C. Labat, C. Boullet, A. Bayol, J. Benveniste, and C. Brink. 1986. Histamine contractions of isolated human airway smooth muscle preparations: role of prostaglandins. J. Pharmacol. Exp. Ther. 239:536-541.
20. Smith, W. L. 1992. Prostanoid biosynthesis and mechanism of action. Am. J. Physiol. 263(Renal Fluid Electrolite Physiol 32):F181-F191.
21. 2 on bronchial reactivity to sodium metabisulphite and methacholine in subjects with asthma. Thorax 46:633-637.
22. Christie, P. E., C. M. Smith, and T. H. Lee. 1991. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353 inhibits aspirin-induced asthma. Am. Rev. Respir. Dis. 144:957-958.
23. Nasser, S. M. S., G. S. Bell, S. Foster, K. E. Spruce, A. MacMillan, A. J. Williams, T. H. Lee, and J. P. Arm. 1994. Effect of the 5-lipoxygenase inhibitor ZD21138 on aspirin-induced asthma. Thorax 49: 749-756.
24. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 143:1025-1029.
25. Israel, E., A. R. Fischer, M. A. Rosenberg, C. M. Lilly, J. C. Callery, J. Shapiro, J. Cohn, P. Rubin, and J. M. Drazen. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148:1447-1451.
26. Sladek, K., and A. Szczeklik. 1993. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur. Respir. J. 6:391-399.
27. Sladek, K., R. Dworski, J. Soja, J. R. Sheller, E. Nizankowska, J. A. Oates, and A. Szczeklik. 1994. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am. J. Respir. Crit. Care Med. 149:940-946.
28. Peters, S. P., E. S. Schulman, D. W. MacGlashan, R. P. Scheimen, H. H. Newball, and L. M. Lichtenstein. 1982. Pharmacologic and biochemical studies of human lung mast cells. J. Allergy Clin. Immunol. 69:150.
29. Tauber, A., M. Kaliner, D. J. Stechschscgulte, and K. F. Austen. 1973. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung: effects of prostaglandins on release of histamine. J. Immunol. 111:27-32.
30. Ferreri, N. R., W. C. Howland, D. D. Stevenson, and H. L. Spiegelberg. 1988. Release of leukotrienes, prostaglandins and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. 137:847-854.
31. 2 on exercise bronchoconstriction in asthmatic subjects. Am. J. Respir. Crit. Care Med. 149: 1138-1141.
32. 4 levels during early and late asthmatic responses. J. Allergy Clin. Immunol. 86:211-220.
33. Hui, K. P., J. K. Taylor, G. W. Taylor, P. Rubin, J. Kesterson, N. C. Barnes, and P. J. Barnes. 1991. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 46:184-189.
34. Nasser, S. M. S., G. S. Bell, R. J. Hawksworth, K. E. Spruce, R. MacMillan, A. Williams, T. H. Lee, and J. P. Arm. 1994. Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses. Thorax 49:743-748.